Posts

Showing posts from June, 2022

Metastatic small cell lung cancer: Symptoms, spread, and more - Medical News Today

Image
Small cell lung cancer is an aggressive cancer that grows and spreads faster than other types of lung cancer. Small cell lung cancer (SCLC) is the least common type of lung cancer, comprising only 15% of all cases. This type of lung cancer tends to grow rapidly and spread early, making it more resistant to treatment. As a result, the disease has associations with more negative outcomes. This article describes what SCLC is, including its symptoms, outlook, and treatment. We also outline the process for diagnosing SCLC and highlight some factors that can influence its spread. SCLC is a type of cancer that begins in the neuroendocrine cells within the lungs. These cells receive messages from neurotransmitters and respond by releasing hormones into the blood. Medical experts sometimes refer to SCLC as oat cell cancer because its oval-shaped cells appear similar to oat grains under a microscope. SCLC is an aggressive type of cancer. Compared with other solid tumors, SCLC has links to one o...

Metastatic small cell lung cancer: Symptoms, spread, and more - Medical News Today

Image
Small cell lung cancer is an aggressive cancer that grows and spreads faster than other types of lung cancer. Small cell lung cancer (SCLC) is the least common type of lung cancer, comprising only 15% of all cases. This type of lung cancer tends to grow rapidly and spread early, making it more resistant to treatment. As a result, the disease has associations with more negative outcomes. This article describes what SCLC is, including its symptoms, outlook, and treatment. We also outline the process for diagnosing SCLC and highlight some factors that can influence its spread. SCLC is a type of cancer that begins in the neuroendocrine cells within the lungs. These cells receive messages from neurotransmitters and respond by releasing hormones into the blood. Medical experts sometimes refer to SCLC as oat cell cancer because its oval-shaped cells appear similar to oat grains under a microscope. SCLC is an aggressive type of cancer. Compared with other solid tumors, SCLC has links to one o...

Nasal Swab Lung Cancer Test: Uses, Procedure, Results, Pros and Cons - Healthline

Image
There are roughly 225,000 new cases of lung cancer every year in the United States. Early diagnosis and treatment play a large role in improving outcomes. A recently developed nasal swab test could help identify the risk of lung cancer so people can proceed with diagnosis and treatment more quickly. While it has some advantages, it may not be a necessary test for everyone. Read on to learn more about the nasal swab lung cancer test, including how and when it's used as well as its benefits and drawbacks. Doctors usually diagnose lung cancer by testing tissue samples in a lab. Doctors get the tissues from your body by taking a biopsy. Biopsies are done using a specialized needle, a specialized tube (bronchoscope) down your throat, or surgery. These methods are all invasive to some degree and can take some time to get results. If the results are negative for cancer, then you've undergone an invasive procedure that could have been avoided. And if the results are positive for cance...

Lung cancer: Plant compound berberine shows promise - Medical News Today

Image
Share on Pinterest New laboratory experiments suggest that plant compound berberine may help fight lung cancer. Image credit: DeAgostini/Getty Images. Lung cancer is the second most common type of cancer in the world, with 1.8 million people dying from the condition in 2020. Researchers from the University of Technology Sydney (UTS) found a plant compound to be effective at stopping the growth of lung cancer cells in a laboratory setting. Researchers plan to further test their findings in preclinical animal models of lung cancer. Lung cancer is the second most common type of cancer in the world. There were more than 2.2 million new diagnoses of lung cancer around the world in 2020. And that same year, globally about 1.8 million people died from lung cancer. While there is currently no cure for lung cancer, scientists are working on treatment options. Some of these scientists are at the University of Technology Sydney (UTS), where a new study found a natural herbal compound called berbe...

Skin cancer on scalp: Melanoma, diagnosis, treatment, and more - Medical News Today

Image
Skin cancer on the scalp may take the form of growths such as ulcers, moles, and sores. These growths can change in appearance. Treatment options vary depending on the type of skin cancer. Skin cancer is the most common type of cancer in the United States. Skin cancer on the scalp may look like a mole, an ulcer, a sore, or another type of growth. Growths on the scalp can change in shape, color, or size and may itch or bleed, which may be concerning for skin cancer. Treatment for skin cancer depends on the type and severity of the cancer. Treatment is more effective if a doctor diagnoses cancer early. This article discusses the different types of skin cancer that can develop on the scalp and their symptoms, diagnosis, and treatment. The type of skin cancer a person has will determine the kind of treatment they receive and influence their outlook. Doctors determine the skin cancer type using a physical examination, blood tests, biopsies, and imaging scans. There are three main types of s...

Metastatic small cell lung cancer: Symptoms, spread, and more - Medical News Today

Image
Small cell lung cancer is an aggressive cancer that grows and spreads faster than other types of lung cancer. Small cell lung cancer (SCLC) is the least common type of lung cancer, comprising only 15% of all cases. This type of lung cancer tends to grow rapidly and spread early, making it more resistant to treatment. As a result, the disease has associations with more negative outcomes. This article describes what SCLC is, including its symptoms, outlook, and treatment. We also outline the process for diagnosing SCLC and highlight some factors that can influence its spread. SCLC is a type of cancer that begins in the neuroendocrine cells within the lungs. These cells receive messages from neurotransmitters and respond by releasing hormones into the blood. Medical experts sometimes refer to SCLC as oat cell cancer because its oval-shaped cells appear similar to oat grains under a microscope. SCLC is an aggressive type of cancer. Compared with other solid tumors, SCLC has links to one o...

Early Signs of Skin Cancer, Says Medical Director — Eat This Not That - Eat This, Not That

Image
In the US skin cancer kills more than 9,000 people each year . New cases per year in the US are in the millions. Most are curable if detected early Skin cancer is caused by overexposure to ultraviolet (UV) radiation from the sun or other sources, such as tanning beds. UV radiation can damage the DNA in our cells. This damage can lead to mutations, or changes, in the DNA that can cause cells Basal cell carcinoma, squamous cell carcinoma, and melanoma are the three most common types of skin cancer. Other types include Kaposi's sarcoma, cutaneous T-cell lymphoma, and Merkel cell carcinoma. Basal cell carcinomas are the most common. They usually appear as small, raised bumps that are smooth, pearly white, or waxy. They can also look like flat, brownish patches with indistinct borders. Basal cell carcinomas can occur anywhere on the body but are most commonly found in areas exposed to the sun such as the head, neck, and hands. Squamous cell c...

New lung cancer treatment combo approved on NHS in England - Cancer Research UK News

Image
Non small cell lung cancer cells. " data-medium-file="https://news.cancerresearchuk.org/wp-content/uploads/2021/11/shutterstock_non-small-cell-lung-cancer-pleural-effusion-300x168.jpg" data-large-file="https://news.cancerresearchuk.org/wp-content/uploads/2021/11/shutterstock_non-small-cell-lung-cancer-pleural-effusion.jpg"> Non small cell lung cancer cells. A new treatment for some people with a type of non small cell lung cancer (NSCLC) will now be routinely available on the NHS in England, following its approval by the National Institute of Health and Care Excellence (NICE). The decision means the immunotherapy drug pembrolizumab (Keytruda), in combination with the chemotherapy drugs carboplatin and paclitaxel, will continue to be an option for adults with untreated, squamous non small cell lung cancer that's spread to other parts of the body. The combination was previously available to people in England through the Cancer Drugs Fund, which gives pe...